Pfizer Q2 Profit Up 25% Despite Stinging Loss Of Lipitor |
| August 01, 2012 | August 2012 Bond Updates |
|
Pfizer says its quarterly profit rose 25%, even as sales of its blockbuster anti-cholesterol drug Lipitor slid further. Still, the pharmaceutical giant completed several steps in new CEO Ian Reed's plan to focus the company on creating big-ticket drugs. |
| View more at: http://www.forbes.com/sites/abrambrown/2012/07/31/pfizer-q2-profit-up-25-despite-stinging-loss-of-lipitor/ |
| Related News |
|